Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas (NF-2)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2013 by University of Alabama at Birmingham
Sponsor:
Collaborator:
Genentech
Information provided by (Responsible Party):
University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT01767792
First received: January 7, 2013
Last updated: January 31, 2014
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)